echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Nature Genetics' world's largest research has found new Alzheimer's genes

    Nature Genetics' world's largest research has found new Alzheimer's genes

    • Last Update: 2023-01-05
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
      


     

     

     

    The researchers identified two new genes
    that increase the risk of developing Alzheimer's disease.
    An international team of Cardiff University's Dementia Research Institute compared 32,000 genetic codes from Alzheimer's patients and healthy people
    .

    The study identified some new genes that contribute to the development of Alzheimer's disease and specific mutations in these genes
    .
    They found rare damaging gene mutations in the ATP8B4 and ABCA1 genes, which may increase the risk of
    Alzheimer's disease.
    The researchers also found evidence of
    gene alternation in another gene, ADAM10.

    Professor Julie Williams, co-author of the study, said: "These findings lead us to very specific processes in the brain, which include differences in the brain's immune system and the way the
    brain processes cholesterol.
    These differences affect brain function and contribute to the development of
    Alzheimer's disease.

    Alzheimer's disease is the most common dementia in the UK
    .
    It is estimated that 60-80% of Alzheimer's disease risk can be explained
    by genetic factors.
    For early-onset Alzheimer's disease (under 65 years of age), this increases to more than
    90%.

    Professor Williams added: "This study helps to broaden our understanding
    of who is at risk of developing this dementia.
    The discovery of these genes also allows us to understand the underlying mechanisms of Alzheimer's disease and create genetic models of the disease in order to develop targeted therapies through new drug treatments and even gene therapies
    in the future.

    The study, titled "Exome sequencing identifies rare disruptive variants in ATP8B4 and ABCA1 as risk factors for Alzheimer's disease," was published in Nature Genetics
    .

    Exome sequencing identifies rare damaging variants in ATP8B4 and ABCA1 as risk factors for Alzheimer's disease


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.